Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation
暂无分享,去创建一个
C. Serhan | E. Andreakos | P. Sideras | C. Tamvakopoulos | A. Chairakaki | Thad W. Vickery | Katerina Pyrillou | O. Koltsida | S. Karamnov
[1] Charles N. Serhan,et al. Molecular circuits of resolution: formation and actions of resolvins and protectins , 2005, The Journal of Immunology.
[2] N. Maheshwari,et al. A Role for the Mouse 12/15-Lipoxygenase Pathway in Promoting Epithelial Wound Healing and Host Defense* , 2005, Journal of Biological Chemistry.
[3] M. Neurath,et al. IL-28A (IFN-λ2) modulates lung DC function to promote Th1 immune skewing and suppress allergic airway disease , 2011, EMBO molecular medicine.
[4] C. Serhan. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. , 2007, Annual review of immunology.
[5] R. Coffman,et al. Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists , 2007, Nature Medicine.
[6] E. Israel,et al. Corticosteroid suppression of lipoxin A4 and leukotriene B4from alveolar macrophages in severe asthma , 2010, Respiratory research.
[7] H. Renz,et al. Immunomodulatory Effects of Viral TLR Ligands on Experimental Asthma Depend on the Additive Effects of IL-12 and IL-101 , 2007, The Journal of Immunology.
[8] De-Quan Li,et al. Short ragweed pollen triggers allergic inflammation through Toll-like receptor 4-dependent thymic stromal lymphopoietin/OX40 ligand/OX40 signaling pathways. , 2011, The Journal of allergy and clinical immunology.
[9] M. Toner,et al. Rapid Appearance of Resolvin Precursors in Inflammatory Exudates: Novel Mechanisms in Resolution1 , 2008, The Journal of Immunology.
[10] J. Kline,et al. Use of CpG oligonucleotides in treatment of asthma and allergic disease. , 2009, Advanced drug delivery reviews.
[11] Adriano G. Rossi,et al. Inflammatory Resolution: new opportunities for drug discovery , 2004, Nature Reviews Drug Discovery.
[12] S. Akira,et al. Pattern Recognition Receptors and Inflammation , 2010, Cell.
[13] Yan Lu,et al. Anti-Inflammatory Actions of Neuroprotectin D1/Protectin D1 and Its Natural Stereoisomers: Assignments of Dihydroxy-Containing Docosatrienes1 , 2006, The Journal of Immunology.
[14] L. Palmer,et al. Diminished lipoxin biosynthesis in severe asthma. , 2005, American journal of respiratory and critical care medicine.
[15] R. Medzhitov. Origin and physiological roles of inflammation , 2008, Nature.
[16] Y. Gho,et al. TH2 and TH1 lung inflammation induced by airway allergen sensitization with low and high doses of double-stranded RNA. , 2007, The Journal of allergy and clinical immunology.
[17] C. Serhan,et al. Metabolomics‐Lipidomics of Eicosanoids and Docosanoids Generated by Phagocytes , 2011, Current protocols in immunology.
[18] E. Israel,et al. Protectin D1 Is Generated in Asthma and Dampens Airway Inflammation and Hyperresponsiveness1 , 2007, The Journal of Immunology.
[19] Eugene Y. Kim,et al. Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4 , 2002, Nature Medicine.
[20] C. Serhan,et al. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. , 2006, The Journal of Immunology.
[21] E. Hamelmann,et al. Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen‐induced Th2 responses, airway inflammation and airway hyper‐reactivity in mice , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[22] E. Puré,et al. Cellular and Molecular Mechanisms of the Selective Regulation of IL-12 Production by 12/15-Lipoxygenase1 , 2006, The Journal of Immunology.
[23] T. van der Poll,et al. Toll-like receptor mRNA levels in alveolar macrophages after inhalation of endotoxin , 2006, European Respiratory Journal.
[24] J Bousquet,et al. Asthma. From bronchoconstriction to airways inflammation and remodeling. , 2000, American journal of respiratory and critical care medicine.
[25] V. Aidinis,et al. Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma. , 2010, American journal of respiratory and critical care medicine.
[26] K. Ohta,et al. Expression and Function of Toll-Like Receptors in Eosinophils: Activation by Toll-Like Receptor 7 Ligand , 2003 .
[27] P. Validire,et al. Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance. , 2010, The Journal of clinical investigation.
[28] S. Johnston,et al. Asthma exacerbations: Origin, effect, and prevention , 2011, Journal of Allergy and Clinical Immunology.
[29] G. Joos,et al. Different roles for human lung dendritic cell subsets in pulmonary immune defense mechanisms. , 2006, American journal of respiratory cell and molecular biology.
[30] C. Serhan. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not? , 2010, The American journal of pathology.
[31] B. Levy,et al. Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation , 2008, Nature Immunology.
[32] Song‐Pyo Hong,et al. Novel Docosanoids Inhibit Brain Ischemia-Reperfusion-mediated Leukocyte Infiltration and Pro-inflammatory Gene Expression* , 2003, Journal of Biological Chemistry.
[33] D. Rader,et al. Selective Interleukin-12 Synthesis Defect in 12/15-Lipoxygenase-deficient Macrophages Associated with Reduced Atherosclerosis in a Mouse Model of Familial Hypercholesterolemia* , 2002, The Journal of Biological Chemistry.
[34] T. Betsuyaku,et al. Dysregulated synthesis of protectin D1 in eosinophils from patients with severe asthma. , 2013, The Journal of allergy and clinical immunology.
[35] R. Locksley,et al. Asthma and Allergic Inflammation , 2010, Cell.
[36] S. Holgate,et al. Treatment strategies for allergy and asthma , 2008, Nature Reviews Immunology.
[37] C. Harding. Choosing and Preparing Antigen‐Presenting Cells , 1997, Current protocols in immunology.
[38] Carl Nathan,et al. Nonresolving Inflammation , 2010, Cell.
[39] Charles N. Serhan,et al. Infection Regulates Pro-Resolving Mediators that Lower Antibiotic Requirements , 2012, Nature.
[40] S. Johnston,et al. The microbiology of asthma , 2012, Nature Reviews Microbiology.
[41] R. Hegde,et al. Allergenicity resulting from functional mimicry of a Toll-like receptor complex protein , 2008, Nature.
[42] P. Taylor,et al. 12/15-Lipoxygenase Regulates the Inflammatory Response to Bacterial Products In Vivo1 , 2008, The Journal of Immunology.
[43] C. Serhan,et al. Conjunctival Goblet Cell Secretion Stimulated by Leukotrienes Is Reduced by Resolvins D1 and E1 To Promote Resolution of Inflammation , 2011, The Journal of Immunology.
[44] Xiaojing Ma. Faculty Opinions recommendation of 12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance. , 2012 .
[45] J. Martin,et al. TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[46] T. Lehtimäki,et al. Toll-Like Receptor 7 Protects From Atherosclerosis by Constraining “Inflammatory” Macrophage Activation , 2012, Circulation.
[47] S. Reuter,et al. TLR3 but Not TLR7/8 Ligand Induces Allergic Sensitization to Inhaled Allergen , 2012, The Journal of Immunology.
[48] R. Medzhitov,et al. Allergic host defences , 2012, Nature.
[49] B. Ryffel,et al. Double-Stranded RNA Exacerbates Pulmonary Allergic Reaction through TLR3: Implication of Airway Epithelium and Dendritic Cells , 2010, The Journal of Immunology.
[50] B. Beutler,et al. Intracellular toll-like receptors. , 2010, Immunity.
[51] Charles N. Serhan,et al. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators , 2008, Nature Reviews Immunology.
[52] D. Umetsu,et al. The many paths to asthma: phenotype shaped by innate and adaptive immunity , 2010, Nature Immunology.
[53] C. Serhan,et al. Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells , 2003, The Journal of Biological Chemistry.
[54] H. Nakanishi,et al. Eosinophils promote resolution of acute peritonitis by producing proresolving mediators in mice , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[55] G. Schett,et al. 12/15-lipoxygenase orchestrates the clearance of apoptotic cells and maintains immunologic tolerance , 2011, Journal of Translational Medicine.
[56] O. Pfaar,et al. Assessment of clinical efficacy of CYT003‐QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study , 2011, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[57] H. Hammad,et al. House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells , 2009, Nature Medicine.
[58] S. Akira,et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88–dependent signaling pathway , 2002, Nature Immunology.
[59] J. Wallace,et al. Resolution of in flammation: state of the art, definitions and terms , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[60] A. Bowie,et al. Sensing and Signaling in Antiviral Innate Immunity , 2010, Current Biology.
[61] C. Serhan,et al. The Docosatriene Protectin D1 Is Produced by TH2 Skewing and Promotes Human T Cell Apoptosis via Lipid Raft Clustering* , 2005, Journal of Biological Chemistry.
[62] A. Jegerlehner,et al. Alveolar Macrophages and Lung Dendritic Cells Sense RNA and Drive Mucosal IgA Responses , 2009, The Journal of Immunology.
[63] M. Gilliet,et al. Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8 , 2009, The Journal of experimental medicine.
[64] F. Horak. VTX-1463, a novel TLR8 agonist for the treatment of allergic rhinitis , 2011, Expert opinion on investigational drugs.
[65] K. Hattermann,et al. The Toll‐like receptor 7/8‐ligand resiquimod (R‐848) primes human neutrophils for leukotriene B4, prostaglandin E2 and platelet‐activating factor biosynthesis , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[66] Andrew E. Parker,et al. Targeting Toll-like receptors: emerging therapeutics? , 2010, Nature Reviews Drug Discovery.
[67] E. Dennis,et al. Omega-3 fatty acids cause dramatic changes in TLR4 and purinergic eicosanoid signaling , 2012, Proceedings of the National Academy of Sciences.
[68] W. Busse,et al. Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma. , 2008, American journal of respiratory and critical care medicine.